humanitarian

Human medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Jylamvo, methotrexate, Date of authorisation: 29/03/2017, Revision: 16, Status: Authorised

Reported by EMA What Is New Sep 7, 2026 · 15:32 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

10 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 3, Status: Authorised15:32 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Xolremdi, mavorixafor, Date of authorisation: 27/04/2026, Revision: 3, Status: Authorised15:32 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 5, Status: Authorised15:20 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 5, Status: Authorised15:20 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Arava, leflunomide, Date of authorisation: 02/09/1999, Revision: 46, Status: Authorised15:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Arava, leflunomide, Date of authorisation: 02/09/1999, Revision: 46, Status: Authorised15:00 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Nordimet, methotrexate, Date of authorisation: 18/08/2016, Revision: 26, Status: Authorised14:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Nordimet, methotrexate, Date of authorisation: 18/08/2016, Revision: 26, Status: Authorised14:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Jylamvo, methotrexate, Date of authorisation: 29/03/2017, Revision: 16, Status: Authorised14:06 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Jylamvo, methotrexate, Date of authorisation: 29/03/2017, Revision: 16, Status: Authorised14:06 UTC

INCIDENT EVOLUTION

4 recorded states

Sep 7 · 16:10 UTC

Signal first indexedP2 · 99% quality · 2 sources

Sep 7 · 16:10 UTC

Source details updatedP2 · 99% quality · 2 sources

Sep 7 · 16:11 UTC

Headline updatedP2 · 99% quality · 2 sources

Sep 7 · 16:15 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →